A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera
Clinical trial NCT05853445 · COMPLETED
Trial details
- NCT number
- NCT05853445
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-08-17
- Primary completion
- 2023-05-03
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.